Ftse Mib
37.977,59
0,00%
DAX
22.482,50
0,00%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
96.198,51
0,07%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Addex Therapeutics Ltd (ADXN) Addex Therapeutics Ltd (ADXN) Notizie

ADXN

Addex Therapeutics (ADXN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADXN
DataOraFonteTitoloSimboloCompagnia
08/01/202507:00GlobeNewswire Inc.Addex to Present at the 2025 Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
22/11/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
22/11/202407:00GlobeNewswire Inc.Addex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/11/202407:00GlobeNewswire Inc.Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024NASDAQ:ADXNAddex Therapeutics Ltd
30/09/202407:00GlobeNewswire Inc.Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
19/09/202407:00GlobeNewswire Inc.Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitNASDAQ:ADXNAddex Therapeutics Ltd
04/09/202407:00GlobeNewswire Inc.Addex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
27/08/202407:00GlobeNewswire Inc.Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationNASDAQ:ADXNAddex Therapeutics Ltd
15/08/202402:12Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
22/07/202407:00GlobeNewswire Inc.Addex’s Partner Discontinues ADX71149 development in EpilepsyNASDAQ:ADXNAddex Therapeutics Ltd
15/07/202407:00GlobeNewswire Inc.Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)NASDAQ:ADXNAddex Therapeutics Ltd
12/07/202407:00GlobeNewswire Inc.Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)NASDAQ:ADXNAddex Therapeutics Ltd
01/07/202407:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Annual General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
06/06/202413:29IH Market NewsUS Index Futures Mixed; Oil Prices RiseNASDAQ:ADXNAddex Therapeutics Ltd
06/06/202407:00GlobeNewswire Inc.Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
05/06/202407:00GlobeNewswire Inc.Addex Convenes Annual General Meeting 2024NASDAQ:ADXNAddex Therapeutics Ltd
31/05/202407:00GlobeNewswire Inc.Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024NASDAQ:ADXNAddex Therapeutics Ltd
08/05/202407:00GlobeNewswire Inc.Addex to Present at Bio€quity Europe 2024NASDAQ:ADXNAddex Therapeutics Ltd
29/04/202407:00GlobeNewswire Inc.Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyNASDAQ:ADXNAddex Therapeutics Ltd
19/04/202407:00GlobeNewswire Inc.Addex to Present at the Swiss Biotech Day 2024NASDAQ:ADXNAddex Therapeutics Ltd
18/04/202407:00GlobeNewswire Inc.Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/04/202407:00GlobeNewswire Inc.Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024NASDAQ:ADXNAddex Therapeutics Ltd
03/04/202407:00GlobeNewswire Inc.Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersNASDAQ:ADXNAddex Therapeutics Ltd
14/03/202407:00GlobeNewswire Inc.Addex to Present at the Bio-Europe Spring 2024 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
31/01/202407:00GlobeNewswire Inc.Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.NASDAQ:ADXNAddex Therapeutics Ltd
30/01/202423:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADXNAddex Therapeutics Ltd
09/01/202407:00GlobeNewswire Inc.Addex to Present at the Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
05/01/202407:30GlobeNewswire Inc.Addex to Present at Biotech Showcase™ 2024NASDAQ:ADXNAddex Therapeutics Ltd
21/12/202312:00Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
20/12/202307:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADXN

La tua Cronologia

DOWI
PCX
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci